News about "Artificial Intelligence"

Transgene, NEC Bio B.V. Sign Licensing Deal to Advance AI-Driven Cancer Vaccine

Transgene, NEC Bio B.V. Sign Licensing Deal to Advance AI-Driven Cancer Vaccine

Transgene's Agreement wirh NEC Bio B.V. to accelerate development of TG4050, a personalised neoantigen immunotherapy for head and neck cancer, combining viral vector technology with AI-based prediction.

Artificial Intelligence | 07/04/2026 | By News Bureau

National Institutes of Health Develops AI Tool to Predict Risk of Intimate Partner Violence

National Institutes of Health Develops AI Tool to Predict Risk of Intimate Partner Violence

Researchers funded by National Institutes of Health have developed an AI-based clinical decision tool that predicts risk of Intimate Partner Violence using routine healthcare data with high accuracy.

Artificial Intelligence | 17/03/2026 | By News Bureau

India-Rwanda Discussions Focus on AI, Bio-Manufacturing and Emerging Technologies

India-Rwanda Discussions Focus on AI, Bio-Manufacturing and Emerging Technologies

Union Minister Dr Jitendra Singh held talks with Rwanda’s ICT leadership to explore collaboration in Artificial Intelligence (AI), genomics, nuclear energy and deep-tech, highlighting startup partnerships and knowledge exchange to strengthen India-Rwanda cooperation.

Artificial Intelligence | 23/02/2026 | By News Bureau 111

Sanofi Announces Euro 1 Billion Share Buyback Programme for 2026

Sanofi Announces Euro 1 Billion Share Buyback Programme for 2026

R&D-driven biopharma major Sanofi to repurchase shares worth up to Euro 1 billion between February and December 2026, reinforcing its capital allocation strategy and long-term growth outlook.

Artificial Intelligence | 04/02/2026 | By News Bureau 241

AstraZeneca Boosts Weight Management Portfolio via CSPC Collaboration

AstraZeneca Boosts Weight Management Portfolio via CSPC Collaboration

Under this agreement, Astrazeneca and CSPC Pharmaceuticals will initially progress four programmes, which utilise CSPC's advanced Artificial Intelligence (AI)-driven peptide drug discovery platform and their proprietary LiquidGel once-monthly dosing platform technology.

Artificial Intelligence | 31/01/2026 | By News Bureau 217

BD Launches Research Cloud 7.0 With AI-Powered Horizon Panel Maker to Advance Flow Cytometry Research

BD Launches Research Cloud 7.0 With AI-Powered Horizon Panel Maker to Advance Flow Cytometry Research

BD has launched Research Cloud 7.0 globally, introducing the AI-driven Horizon Panel Maker to automate panel design, streamline workflows and enhance data quality in immunology and cancer research.

Artificial Intelligence | 27/01/2026 | By News Bureau 248

Insilico Medicine, Hygtia Therapeutics Partner to Co-Develop AI-Designed NLRP3 Inhibitor for CNS Disorders

Insilico Medicine, Hygtia Therapeutics Partner to Co-Develop AI-Designed NLRP3 Inhibitor for CNS Disorders

Insilico Medicine and Hygtia Therapeutics have entered a co-development deal for ISM8969, an AI-designed, brain-penetrant NLRP3 inhibitor, with milestone payments of up to USD 66 million.

Artificial Intelligence | 21/01/2026 | By News Bureau 199

Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants

Experts Highlight Need for AI-Based Quality and Traceability in Medicinal Plants

Experts at a national seminar hosted by IIT Delhi emphasised the need for AI-enabled farm-gate quality assessment and traceability to strengthen India’s medicinal plant supply chain, outlining a digital roadmap to enhance the global competitiveness of AYUSH raw materials.

Artificial Intelligence | 13/01/2026 | By News Bureau 144

23rd BioAsia to be Held from 16 to 18 Feb in Hyderabad

23rd BioAsia to be Held from 16 to 18 Feb in Hyderabad

The Telangana government has launched BioAsia 2026, highlighting the summit’s focus on TechBio, AI and automation as key drivers reshaping life sciences, healthcare innovation and global health systems.

Artificial Intelligence | 12/01/2026 | By News Bureau 126

Variant Bio partners with Boehringer Ingelheim for Research on Kidney Disease

Variant Bio partners with Boehringer Ingelheim for Research on Kidney Disease

The multi-year collaboration with Boehringer Ingelheim will leverage Variant Bio’s AI-powered Inference platform to identify novel kidney disease drug targets, with financial terms including upfront, licence and milestone payments that could exceed USD 120 million.

Artificial Intelligence | 08/01/2026 | By News Bureau 163


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members